WebNov 4, 2024 · Dynavax Technologies, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $108.27 million for the quarter ended September 2024, surpassing the Zacks Consensus... WebNov 8, 2024 · The earnings estimate of $0.36 per share for the current quarter represents a change of -34.55% from the number reported a year ago. The Zacks Consensus Estimate for Dynavax Technologies has...
Dynavax Technologies Corporation (DVAX) Earnings Report
WebApr 9, 2024 · By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Dynavax Technologies became profitable ... Web1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Dynavax Technologies (DVAX) orbicularis oris 뜻
DVAX Dynavax Technologies Corp. Financial Statements - WSJ
WebNov 3, 2024 · Dynavax Technologies (DVAX) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.06 per share a year... WebMay 5, 2024 · Dynavax Technologies (DVAX) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.01 per share a year ago. WebApr 11, 2024 · Dynavax Technologies (NASDAQ:DVAX - Get Rating) last issued its quarterly earnings data on Thursday, February 23rd. The biopharmaceutical company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.01). Dynavax Technologies had a return on equity of 65.26% and a net margin of 40.56%. ipod 4 converter to ipod 5